Medikationsfehler in der Intensivmedizin

• Literatur

• 1 Kohn LT, Corrigan JM, Donaldson MS et al. To err is human. Building a safer health system. Washington (DC): National Academies Press (US); 2000
• 2 Käfer M. Das Arbeitsschutzysystem bei DuPont de Nemours. Düsseldorf: Hans Böckler Stiftung; 2009
• 3 Valentin A, Capuzzo M, Guidet B et al. Errors in administration of parental drugs in intensive care units: multinational prospective study. BMJ 2009; 338: b814
• 4 Carayon P, Wetterneck TB, Cartmill R et al. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units. BMJ Qual Saf 2014; 23: 56-65
• 5 Mellin-Olsen J, Staender S, Whitaker DK et al. The Helsinki Declaration on patient safety in anesthesiology. Eur J of Anesthesiology 2010; 27: 592-597
• 6 Bundesministerium für Gesundheit. Aktionsplan 2013–2015 des Bundesministeriums für Gesundheit zur Verbesserung der Arzneimitteltherapiesicherheit in Deutschland. Im Internet: http://www.bmg.bund.de/fileadmin/dateien/Downloads/A/Arzneimittelversorgung/Aktionsplan_2013_-_2015.pdf
• 7 Löffler K. Die sachgerechte Arzneimittellagerung in der Arztpraxis. Praxisorganisation 2009; 12: 3
• 8 Anonym. Ciclosporin: Vorsicht beim Wechsel der Formulierung. Dtsch Ärztebl 2001; 98: A 2600
• 9 Noe-Schwenn S, Lipp HP. Preisgünstige Therapiealternativen nach § 115c SGB V: Vergleichstabelle der CSE-Hemmer. Krankenhauspharmazie 2003; 24: 509-516
• 10 Kommission für Krankenhaushygiene und Infektionsprävention, Robert Koch Institut. Anforderungen an die Hygiene bei Punktionen und Injektionen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 54. 1135-1144
• 11 Jensen LS, Merry AF, Webster CS et al. Evidence-based strategies for preventing drug administration errors during anesthesia. Anesthesia 2004; 59: 493-504
• 12 International Organization for Standardization. Anaesthetic and respiratory equipment: User-applied labels for syringes containing drugs used during anaesthesia – Colours, design and performance. ISO 26825:2008(E). Geneva: ISO; 2008
• 13 Kommission für Arzneimittelsicherheit der DIVI. Empfehlung zur Kennzeichnung von Spritzen in der Intensiv- und Notfallmedizin. DIVI; 2010 1. 8-11
• 14 Kommission für Arzneimittelsicherheit der DIVI. Empfehlung zur Kennzeichnung von Spritzen in der Intensiv- und Notfallmedizin 2012 – erste Überarbeitung des „DIVI-Standards“. Im Internet: 2012 http://www.divi.de/images/Dokumente/Empfehlungen/Spritzenetiketten/DIVI-Etiketten-Empfehlung_2012_07_02.pdf
• 15 Parshuram CS, To T, Seto W et al. Systematic evaluation of errors occurring during the preparation of intravenous medication. CMAJ 2008; 178: 42-48
• 16 Dehmel C, Braune SA, Kreymann G et al. Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward?. Intensive Care Med 2011; 37: 1311-1316
• 17 Aguado-Lorenzo V, Weeks K, Tunstell P et al. Accuracy of the concentration of morphine infusions prepared for patients in a neonatal intensive care unit. Arch Dis Child 2013; 98: 975-979
• 18 Newton DW. Drug incompatibility chemistry. Am J Health Syst Pharm 2009; 66: 348-357
• 19 Kanji S, Lam J, Johanson C et al. Systematic review of physical and chemical compatibility of commonly used medication administered by continuous infusion in intensive care units. Crit Care Med 2010; 38: 1890-1898
• 20 Nemec K, Kopelent-Frank H, Greif R. Standardization of infusion solutions to reduce the risk of incompatibility. Am J Health Syst Pharm 2008; 65: 1648-1654
• 21 Fissel WH. Antimicrobial Dosing in Acute Renal Replacement. Adv Chronic Kidney Dis 2013; 20: 85-93
• 22 Jamal JA, Udy AA, Lipman J et. al The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimes. Crit Care Med 2014; 42: 640-650
• 23 Nosseir NS, Michels G, Pfister R et. al Therapeutisches Drug Monitoring (TDM) von Antiinfektiva in der Intensivmedizin. Dtsch Med Wochenschr 2014; 139: 1889-1894
• 24 Udy AA, De Waele JJ, Lipman J. Augmented renal clearance and therapeutic monitoring of β-lactams. Int J Antimicrob Agents 2015;
• 25 Abdul-Aziz MH, McDonald C, McWhinney B et al. Low flucloxacillin concentration in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid monitoring in the ICU. Ann Pharmacother 2014; 48: 1380-1384
• 26 Taccone FS, Laterre PF, Dugernier T et al. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 2010; 14: R126
• 27 Nakamura Y, Takeuchi H, Okuyama K et al. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy. Transplantation Proceedings 2005; 37: 1725-1727
• 28 Rindone JP, Sloane EP. Cyanide toxicity from sodium nitroprusside: risks and management. Ann Pharmacother 1992; 26: 515-519
• 29 Walker IA, Griffiths R, Qilson IH. Replacing Luer connectors: still work in progress. Anaesthesia 2010; 65: 1059-1063
• 30 Rohe J, Schleppers A, Sanguino A et al. CIRSains Special. Anästh Intensivmed 2011; 52: 244-247